Sunday, May 6, 2012
GM bankruptcy expected by June 1 - The Business Journal of Milwaukee:
“I don’t know all the details but I wouled expect General Motors to go right up tothe deadline,” said Garryy Graber, a lawyer with Hodgsojn Russ who specializes in business bankruptcies. Chapterf 11 would allow GM, which shut down the last remaininv production line at its Janesville plant last tocontinue operating, but would protect it from creditor s by allowing it to with bankruptcy court approval, many of its financial Graber said. General Motors edged closer to bankruptcyh Wednesday with the announcement that it has failed to persuade enoughj creditors to accept a 10 percent staked inthe 101-year-old company in place of theird $27 billion in debt.
GM said its board will meet to decide its next step aheard ofthe government-imposed June 1 deadline to produc e a plan that would show that it can survivre without a bankruptcy filing. Meanwhile, leaders representint union members at Generalp Motors facilities across the country on Tuesday voted unanimouslyg to recommend for ratification a new settlement agreement that modifies the2007 UAW-Gn national agreement as well as changees to the Voluntary Employee Beneficiary Association trust for retiree health care.
Saturday, May 5, 2012
FDA okays Hologic birth control system - Houston Business Journal:
Company officials say the system is designer to provide womena less-invasive alternative to tubal The procedure does not involve an incision and can be performed in a doctor’zs office using local anesthesia. In January Hologic received European approval for the Adiana system and commencee marketing and sales of this product in certainEuropean countries. The Adian procedure is indicated for womeh who desire permanent birt h control by occlusion of the fallopian In theAdiana procedure, a slender, flexible instrument is inserted to deliver a low level of radiofrequency (RF) energy to a smal section of each fallopian tube, companyh officials say.
Then a tiny, soft insert about the size of a graim ofrice — is placed in each fallopiab tube. During the three months following the the patient continues to use temporargy birth control while new tissue grows in and aroundd theAdiana inserts, eventually blockingv the fallopian tubes. At three months, a speciapl x-ray test is performed to confirj the fallopian tubes are completely blocked and the patient may begin relyingb on Adiana forpermanent
Thursday, May 3, 2012
HomeTeam Huddle: Stewart the centerpiece of Gibbs' game plan - Tampabay.com (blog)
HomeTeam Huddle: Stewart the centerpiece of Gibbs' game plan Tampabay.com (blog) ST. PETERSBURG - Gibbs' Emmanuel Stewart tore the ACL in his left knee during the second game of last season. He is back on the practice field for the first time since that injury, and according to second-year coach Antonio Knox, he's at full strength. |
Tuesday, May 1, 2012
Zammuto Plays at Glasslands Gallery - New York Times
Zammuto Plays at Glasslands Gallery New York Times ... Gallery on Monday night with songs from its new album, also called âZammutoâ (Temporary Residence), that merge the nimble, the knotty, the philosophical and the pensive, living up to song titles like âToo Late to Topologizeâ and âIdiom Wind. |
Sunday, April 29, 2012
Miss Manners: Make grandma happy with e-mails of your own - Washington Post
Miss Manners: Make grandma happy with e-mails of your own Washington Post My grandmother sends me dozens of forwarded e-mails each week with information such as âwatch out for new virus.â I try to be respectful, and even spent some time last semester trying to reply to each e-mail she sent, despite the fact that it was ... |
Saturday, April 28, 2012
Software maker Epocrates quietly performs facelift - Silicon Valley / San Jose Business Journal:
The privately held San Mateo which provides clinical informatiojnand decision-support software to doctors and other bid farewell to Kirk Loevner, its formed chairman, president and CEO, in Decembe r and in early March name Rose Crane, a former pharmaceutical executive, as its new chiefr executive. Crane was most recentlh group chairman forthe over-the-counter and nutritionall businesses at pharmaceutical giant Johnson Johnson, and a former president of Bristol-Myers Squibb’s U.S. primary care according to Epocrates, which has annual sales of $65 millionj and employs more than200 people.
Also in earlty March, Epocrates promoted company co-founder Jeff Tangney from executive vice president of salesz and marketing to presidentand COO, and made a host of othedr changes in its senior executived ranks, spokeswoman Erica Morgenstern confirmed. Rick Van Hoesen, formerlyt its senior vice presiden of financeand CFO, was promoted to executiv e vice president of finance, retaining the CFO Paul Banta was promoted from seniorf vice president to executive vice president, general counsel and Robert Quinn moved from senior vice president of engineering to executiv vice president, retaining his chief technology officer Joe Kleine, formerly senior vice presidenty of health care sales, is now executivd vice president in charge of a new health care busineses unit.
Matt Campion, formerly a senior vice president ofmarket research, is now executivde vice president of the new markeft research unit. Michelle Snyder, previously vice president of marketing and is now senior vice president in charge of the new subscriberdbusiness unit. Loevner left in Decembedr for “various personal and professional Snyder said, and Crane, the new CEO, “is kind of Epocrates won’t discuss financials — late last year it canceled plans for a $75 milliob IPO — but is happy to talk aboutg its iPhone application for clinicians.
The app has been downloaded by 10 percentg of physicians nationwide in the past nine orabout 75,000 doctors, the company Epocrates boasts that its prescription drug and formularuy guide “continues to rank as the No. 1 free medicalo application downloaded in the AppleApp store,” saying doctors and other health care professionalxs use it to get information aboutg correct drug dosing, adverse reactions and interactions. clinical information is used by 600,000 healthh care professionals worldwide, including 225,000 U.S. doctors. Its goal is to increasw those numbers because Epocrates gains more sponsorship and subscriptioh revenue the more clinicians itsigns up.
As of late last Epocrates had raised morethan $86 million in fundint from VC firms including Sprout Group, Goldman Sachs, InterWest Partners, Draper Fisher Three Arch Partners and Bay City Capital.
Thursday, April 26, 2012
IXYS Introduces a Higher Efficiency Higher Power Bipolar Module - The MCMA140 ... - MarketWatch (press release)
IXYS Introduces a Higher Efficiency Higher Power Bipolar Module - The MCMA140 ... MarketWatch (press release) BIEL, Switzerland, Apr 26, 2012 (BUSINESS WIRE) -- IXYS Corporation (NASDAQ:IXYS) , a leader in power semiconductors and integrated circuits technologies for energy efficient products for power conversion and motor control applications, announced today ... |